GWAS typically involve collecting DNA samples from a large group of individuals, some of whom have the disease (cases) and some of whom do not (controls). Researchers then examine millions of single nucleotide polymorphisms (SNPs) across the genome to identify those that are more common in cases than in controls. By doing so, they can identify genetic loci that may contribute to disease risk.
